Download PDF
Thromb Haemost 2015; 114(02): 440-444
DOI: 10.1160/TH14-11-0973
Letters to the Editor
Schattauer GmbH

Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update

Manuel Cappellari
1   Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Universitaria Integrata Verona, Italy
,
Paolo Bovi
1   Stroke Unit, Division of Neurology, Department of Neuroscience, Azienda Ospedaliera Universitaria Integrata Verona, Italy
› Author Affiliations
Further Information

Publication History

Received: 24 November 2014

Accepted after major revision: 29 January 2015

Publication Date:
29 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Jauch EC, Saver JL, Adams Jr HP. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013; 44: 870-947.
    CrossrefPubMedGoogle Scholar
  • 2 De Smedt A, De Raedt S, Nieboer K. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran. Cerebrovasc Dis 2010; 30: 533-534.
    CrossrefPubMedGoogle Scholar
  • 3 Inaishi J, Nogawa S, Mano Y. et al. Successful thrombolysis without hemorrhage in a patient with cardioembolic stroke under dabigatran treatment-a case report and review of literature. Rinsho Shinkeigaku 2014; 54: 238-240.
    CrossrefPubMedGoogle Scholar
  • 4 Matute MC, Guillán M, García-Caldentey J. et al. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran. Thromb Haemost 2011; 106: 178-179.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE. et al. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran. Cerebrovasc Dis 2011; 32: 614-615.
    CrossrefPubMedGoogle Scholar
  • 6 Sangha N, El Khoury R, Misra V. et al. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization. J Stroke Cerebrovasc Dis 2012; 21: 917.e5-8.
    PubMedGoogle Scholar
  • 7 Marrone LC, Marrone AC. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report. Cerebrovasc Dis 2012; 34: 246-247.
    CrossrefPubMedGoogle Scholar
  • 8 Lee VH, Conners JJ, Prabhakaran S. Intravenous thrombolysis in a stroke patient taking dabigatran. J Stroke Cerebrovasc Dis 2012; 21: 916.e11-2.
    PubMedGoogle Scholar
  • 9 Pfeilschifter W, Abruscato M, Hövelmann S. et al. Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases.ase. Rep Neurol 2013; 05: 56-61.
    PubMedGoogle Scholar
  • 10 Jayathissa S, Gommans J, Harper P. Stroke thrombolysis in patients taking dabigatran. Intern Med J 2013; 43: 826-828.
    CrossrefPubMedGoogle Scholar
  • 11 Breuer L, Ringwald J, Schwab S. et al. Ischemic stroke in an obese patient receiving dabigatran. N Engl J Med 2013; 368: 2440-2442.
    CrossrefPubMedGoogle Scholar
  • 12 Kate M, Szkotak A, Witt A. et al. Proposed Approach to Thrombolysis in Dabigatran-Treated Patients Presenting with Ischemic Stroke. J Stroke Cerebrovasc Dis 2014; 23: 1351-1355.
    CrossrefPubMedGoogle Scholar
  • 13 Diogo C, Nzwalo H, Sobral S. et al. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran. Am J Emerg Med 2014; 32: 1435.e1-2.
    CrossrefPubMedGoogle Scholar
  • 14 Tabata E, Yasaka M, Wakugawa Y. et al. Recombinant tissue-type plasminogen activator (rt-PA) therapy in an acute stroke patient taking dabigatran etexilate: a case report and literature review. Intern Med 2014; 53: 1515-1517.
    CrossrefPubMedGoogle Scholar
  • 15 Govindarajan R, Galvez N. Is intravenous recombinant tissue plasminogen activator (r-tPA) safe in patients on Dabigatran?. J Vasc Interv Neurol 2014; 07: 21-22.
    PubMedGoogle Scholar
  • 16 Staikov I, Mihnev N. Intravenous Thrombolytic Treatment of Acute Ischemic Stroke in Patient on Dabigatran. Am J Neuroprotect Neuroregen 2014; 06: 69-72.
    CrossrefPubMedGoogle Scholar
  • 17 Fluri F, Heinen F, Kleinschnitz C. Intravenous thrombolysis in a stroke patient receiving rivaroxaban. Cerebrovasc Dis Extra 2013; 03: 153-155.
    CrossrefPubMedGoogle Scholar
  • 18 Kawiorski MM, Alonso-Canovas A, de Felipe Mimbrera A. et al. Successful intravenous thrombolysis in acute ischaemic stroke in a patient on rivaroxaban treatment. Thromb Haemost 2014; 111: 557-558.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Seiffge DJ, Traenka C, Gensicke H. et al. Intravenous thrombolysis in stroke patients receiving rivaroxaban. Eur J Neurol 2014; 21: e3-e4.
    CrossrefPubMedGoogle Scholar
  • 20 Van Hooff RJ, Nieboer K, De Smedt A. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke in a patient treated with rivaroxaban. Clin Neurol Neurosurg 2014; 122: 133-134.
    CrossrefPubMedGoogle Scholar
  • 21 Bornkamm K, Harloff A. Safe intravenous thrombolysis in acute stroke despite treatment with rivaroxaban. J Clin Neurosci 2014; 21: 2012-2013.
    CrossrefPubMedGoogle Scholar
  • 22 Ishihara H, Torii H, Imoto H. et al. Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Rivaroxaban. J Stroke Cerebrovasc Dis 2014; 23: e457-459.
    CrossrefPubMedGoogle Scholar
  • 23 Neal AJ, Campbell BC, Chandratheva A. et al. Intravenous thrombolysis for acute ischaemic stroke in the setting of rivaroxaban use. J Clin Neurosci 2014; 21: 2013-2015.
    CrossrefPubMedGoogle Scholar
  • 24 De Smedt A, Cambron M, Nieboer K. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with apixaban. Int J Stroke 2014; 09: E31.
    CrossrefPubMedGoogle Scholar
  • 25 Kimura S, Ogata T, Fukae J. et al. Revascularization for acute ischemic stroke is safe for rivaroxaban users. J Stroke Cerebrovasc Dis 2014; 23: e427-431.
    CrossrefPubMedGoogle Scholar
  • 26 Korya D, Dababneh H, Moussavi M. et al. Intravenous thrombolysis in a patient using factor Xa inhibitor. J Vasc Interv Neurol 2014; 07: 1-4.
    PubMedGoogle Scholar
  • 27 Xian Y, Liang L, Smith EE. et al. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. J Am Med Assoc 2012; 307: 2600-2608.
    PubMedGoogle Scholar
  • 28 Steiner T, Böhm M, Dichgans M. et al. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol 2013; 102: 399-412.
    CrossrefPubMedGoogle Scholar
  • 29 Hawes EM, Deal AM, Funk-Adcock D. et al. Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels. Thromb Haemost 2013; 11: 1493-1502.
    CrossrefPubMedGoogle Scholar
  • 30 McGrath ER, Eikelboom JW, Kapral MK. et al. Novel oral anticoagulants: a focused review for stroke physicians. Int J Stroke 2014; 09: 71-78.
    CrossrefPubMedGoogle Scholar